학술논문
A Phase 2 Study to Evaluate the Efficacy and Safety of Simtuzumab in Adult Subjects with Primary, Post Polycythemia Vera (PV) or Post Essential Thrombocythemia (ET) Myelofibrosis
Document Type
Abstract
Author
Source
In Blood 3 December 2015 126(23):2810-2810
Subject
Language
ISSN
0006-4971